Literature DB >> 15899300

Incidence of and survival after mammary tumors in a population of over 80,000 insured female dogs in Sweden from 1995 to 2002.

Agneta Egenvall1, Brenda N Bonnett, Patrik Ohagen, Pekka Olson, Ake Hedhammar, Henrik von Euler.   

Abstract

The main objective of this study was to describe the incidence of mammary tumors (MTs) and the survival after MTs, in female dogs between 3 and 10 years of age (insured for veterinary care and with life insurance in a Swedish animal-insurance company) from 1995 to 2002. Measures of incidence are presented crudely, by breed and across age categories and birth cohorts (1991-1998). The survivals until MT diagnosis and after a MT diagnosis were computed. The overall incidence for any MT claim was 111 dogs per 10,000 dog-years at risk (DYAR). The overall MT rate in the 1992 and 1993 birth cohorts was 154 dogs per 10,000 DYAR. The incidence for any MT claim increased with age and varied by breed, from 319 dogs per 10,000 DYAR in the English springer spaniel to 5 dogs per 10,000 DYAR in the rough-haired collie. At the ages 6, 8 and 10 years, 1%, 6% and 13% respectively, of all females had at least one MT claim. The MT mortality was 6 deaths per 10,000 DYAR and increased with age. The overall-case fatality was 6%.

Entities:  

Mesh:

Year:  2005        PMID: 15899300     DOI: 10.1016/j.prevetmed.2005.01.014

Source DB:  PubMed          Journal:  Prev Vet Med        ISSN: 0167-5877            Impact factor:   2.670


  57 in total

Review 1.  Man's best friend becomes biology's best in show: genome analyses in the domestic dog.

Authors:  Heidi G Parker; Abigail L Shearin; Elaine A Ostrander
Journal:  Annu Rev Genet       Date:  2010       Impact factor: 16.830

2.  Genetic variations of BRCA1 and BRCA2 genes in dogs with mammary tumours.

Authors:  S O Enginler; I Akış; T S F Toydemir; K Oztabak; D Haktanir; M C Gündüz; I Kırşan; I Fırat
Journal:  Vet Res Commun       Date:  2013-10-13       Impact factor: 2.459

3.  MicroRNA-21 expression, serum tumor markers, and immunohistochemistry in canine mammary tumors.

Authors:  Eman S Ramadan; Noha Y Salem; Ibrahim A Emam; Naglaa A AbdElKader; Haithem A Farghali; Marwa S Khattab
Journal:  Vet Res Commun       Date:  2021-11-17       Impact factor: 2.459

4.  Bone tumors in a population of 400 000 insured Swedish dogs up to 10 y of age: incidence and survival.

Authors:  Agneta Egenvall; Ane Nødtvedt; Henrik von Euler
Journal:  Can J Vet Res       Date:  2007-10       Impact factor: 1.310

5.  General assessment of copy number variation in normal and tumor tissues of the domestic dog (Canis lupus familiaris).

Authors:  Artur Gurgul; Kacper Żukowski; Brygida Ślaska; Ewelina Semik; Klaudia Pawlina; Tomasz Ząbek; Igor Jasielczuk; Monika Bugno-Poniewierska
Journal:  J Appl Genet       Date:  2014-02-27       Impact factor: 3.240

Review 6.  Insurance data for research in companion animals: benefits and limitations.

Authors:  Agneta Egenvall; Ane Nødtvedt; Johanna Penell; Lotta Gunnarsson; Brenda N Bonnett
Journal:  Acta Vet Scand       Date:  2009-10-29       Impact factor: 1.695

Review 7.  Leading the way: canine models of genomics and disease.

Authors:  Abigail L Shearin; Elaine A Ostrander
Journal:  Dis Model Mech       Date:  2010 Jan-Feb       Impact factor: 5.758

8.  Expression of Periostin in Mammary Cancer Cells of Female Dogs.

Authors:  Paulina Borecka; Rafal Ciaputa; Izabela Janus; Joanna Bubak; Aleksandra Piotrowska; Katarzyna Ratajczak-Wielgomas; Marzenna Podhorska-OkolÓw; Piotr DziĘgiel; Marcin Nowak
Journal:  In Vivo       Date:  2020 Nov-Dec       Impact factor: 2.155

9.  Analysis of lysyl oxidase as a marker for diagnosis of canine mammary tumors.

Authors:  Afnan Saleem; Satparkash Singh; B V Sunil Kumar; Jaspreet Singh Arora; Ratan Kumar Choudhary
Journal:  Mol Biol Rep       Date:  2019-07-01       Impact factor: 2.316

10.  Effects of the missense mutations in canine BRCA2 on BRC repeat 3 functions and comparative analyses between canine and human BRC repeat 3.

Authors:  Yasunaga Yoshikawa; Kazuhiko Ochiai; Masami Morimatsu; Yu Suzuki; Seiichi Wada; Takahiro Taoda; Satomi Iwai; Seishiro Chikazawa; Koichi Orino; Kiyotaka Watanabe
Journal:  PLoS One       Date:  2012-10-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.